Windtree Therapeutics (NASDAQ:WINT – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($20.91) earnings per share (EPS) for the quarter, missing the consensus estimate of ($8.11) by ($12.80), Zacks reports.
Windtree Therapeutics Stock Up 1.9 %
Shares of Windtree Therapeutics stock opened at $11.43 on Wednesday. The stock has a market cap of $6.77 million, a price-to-earnings ratio of -0.31 and a beta of 0.55. Windtree Therapeutics has a twelve month low of $2.81 and a twelve month high of $27.00. The company’s fifty day moving average is $5.81 and its 200 day moving average is $5.71.
About Windtree Therapeutics
Further Reading
- Five stocks we like better than Windtree Therapeutics
- How to Evaluate a Stock Before Buying
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
- P/E Ratio Calculation: How to Assess Stocks
- Traditional IRA vs. Roth IRA vs. 401(k): A Comparison
- EV Stocks and How to Profit from Them
- Is AMD Closing the Gap with Nvidia After its Recent Acquisition?
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.